Diagnostic accuracy and radiomic analysis of 68Ga-DOTATOC PET for preoperative assessment of lymph nodal status in well-differentiated pancreatic neuroendocrine tumours

被引:0
|
作者
Bezzi, Carolina [1 ]
Mapelli, Paola [2 ]
Ghezzo, Samuele [1 ]
Muffatti, Francesca [3 ]
Lena, Marco Schiavo [2 ]
Andreasi, Valentina [2 ]
Canevari, Carla [2 ]
Magnani, Patrizia [2 ]
Partelli, Stefano [2 ]
Falconi, Massimo [2 ]
Picchio, Maria [4 ]
机构
[1] Univ Vita Salute San Raffaele, Milan, Italy
[2] IRCCS San Raffaele Sci Inst, Milan, Italy
[3] IRCCS San Raffaele Sci Inst, Pancreat Surg Unit, Pancreas Translat & Clin Res Ctr, Via Olgettina 60, I-20132 Milan, Italy
[4] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst, Milan, Italy
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
P616
引用
收藏
页数:3
相关论文
共 42 条
  • [31] Diagnostic performance of a whole-body dynamic 68GA-DOTATOC PET/CT acquisition to differentiate physiological uptake of pancreatic uncinate process from pancreatic neuroendocrine tumor
    Thuillier, Philippe
    Bourhis, David
    Karakatsanis, Nicolas
    Schick, Ulrike
    Metges, Jean Philippe
    Salaun, Pierre-Yves
    Kerlan, Veronique
    Abgral, Ronan
    MEDICINE, 2020, 99 (33) : E20021
  • [32] Prognostic value of total tumor volume with 68Ga DOTATOC PET/CT in predicting response to 177-Lu-DOTATOC treatment in metastatic well-differentiated neuroendocrine tumors (NETs)
    Vega-Zolano, Elizabeth
    Ruiz, Erika
    Caderillo-Ruiz, German
    Diaz, Consuelo
    Herrera, Marytere
    Torres Agredo, Liliana Patricia
    Soldevilla-Gallardo, Irma
    Michel-Sanchez, Emiliano
    Garcia-Perez, Francisco Osvaldo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Tumor-to-Liver Ratio of Ga-68-DOTATOC PET/CT as a Prognostic Parameter in Metastatic, Well-Differentiated Gastroenteropancreatic-Neuroendocrine Tumor Patients Who Received Lanreotide Therapy
    Kim, Y., I
    Yoo, C.
    Ryoo, B. Y.
    Ryu, J. S.
    NEUROENDOCRINOLOGY, 2020, 110 : 260 - 260
  • [34] Tumour-to-liver ratio determined by [68Ga]Ga-DOTA-TOC PET/CT as a prognostic factor of lanreotide efficacy for patients with well-differentiated gastroenteropancreatic-neuroendocrine tumours
    Kim, Yong-il
    Yoo, Changhoon
    Oh, Seung Jun
    Lee, Sang Ju
    Kang, Junho
    Hwang, Hee-Sang
    Hong, Seung-Mo
    Ryoo, Baek-Yeol
    Ryu, Jin-Sook
    EJNMMI RESEARCH, 2020, 10 (01)
  • [35] Predictive value of 68[Ga]Ga-DOTA-TATE PET/CT volumetric parameters in assessing treatment response to long-acting somatostatin analogues in patients with well-differentiated neuroendocrine tumours
    Morawiec-Slawek, Karolina
    Opalinska, Marta
    Lenda-Tracz, Wioletta
    Sitarz, Katarzyna
    Kurzynska, Anna
    Stefanska, Agnieszka
    Kolasa, Magdalena
    Sowa-Staszczak, Anna
    Hubalewska-Dydejczyk, Alicja
    EJNMMI RESEARCH, 2024, 14 (01):
  • [36] Tumour-to-liver ratio determined by [68Ga]Ga-DOTA-TOC PET/CT as a prognostic factor of lanreotide efficacy for patients with well-differentiated gastroenteropancreatic-neuroendocrine tumours
    Yong-il Kim
    Changhoon Yoo
    Seung Jun Oh
    Sang Ju Lee
    Junho Kang
    Hee-Sang Hwang
    Seung-Mo Hong
    Baek-Yeol Ryoo
    Jin-Sook Ryu
    EJNMMI Research, 10
  • [37] The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors
    Duygu Has Simsek
    Yunus Guzel
    Dilara Denizmen
    Yasemin Sanli
    Fikret Buyukkaya
    Bilal Kovan
    Halil Komek
    Emine Goknur Isik
    Zeynep Gozde Ozkan
    Serkan Kuyumcu
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 828 - 840
  • [38] The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors
    Simsek, Duygu Has
    Guzel, Yunus
    Denizmen, Dilara
    Sanli, Yasemin
    Buyukkaya, Fikret
    Kovan, Bilal
    Komek, Halil
    Isik, Emine Goknur
    Ozkan, Zeynep Gozde
    Kuyumcu, Serkan
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (03) : 828 - 840
  • [39] Well-differentiated grade 3 neuroendocrine tumours and poorly differentiated grade 3 neuroendocrine carcinomas: will dual tracer PET-computed tomography (68Ga-DOTATATE and FDG) play a pivotal role in differentiation and guiding management strategies?
    Basu, Sandip
    Adnan, Aadil
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (10) : 1086 - 1087
  • [40] Head-to-Head Comparison of 68Ga-NODAGA-JR11 and 68Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: Interim Analysis of a Prospective Bicenter Study
    Lin, Zefang
    Zhu, Wenjia
    Zhang, Jiaying
    Miao, Weibing
    Yao, Shaobo
    Huo, Li
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (09) : 1406 - 1411